Le principal risque vient des usages dtourns, notamment les injections non mdicales
Poor candidates People who want maximum effectiveness
For others, it may continue past that point
As Wegovy lowers insulin demand, your body adjusts to new glucose patterns
If you want the broader landscape (and the list of other peptides driving search interest), see Metos internal piece: 14 Peptides Are About to Become Legal Again What This Means for Your Health. Who should consider AOD-9604 (and who shouldnt) Consider it only if your expectations are realistic AOD-9604 may be worth a conversation if you are: Already doing the fundamentals (protein, resistance training, sleep) Not seeking massive scale weight loss Looking at fat-loss support rather than appetite suppression Intolerant of GLP-1s and exploring alternatives (with the understanding that alternatives are usually less powerful) Avoid it if You have significant obesity and need a high-efficacy therapy (GLP-1/GIP class is typically far more impactful) (PubMed) Youre hoping it will melt fat without dietary alignment Your plan depends on unverified sources or research peptide suppliers Youre in a drug-tested sport environment (WADA prohibition is relevant) (wada-ama.org) Practical expectations (what most people want to know) How fast does it work
While compounded semaglutide is not FDA-approved as a finished product, it contains the same active pharmaceutical ingredient as FDA-approved Wegovy and is held to rigorous quality, sterility, and potency standards
)